Manchester Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.78M | Buy |
19,010
+37
| +0.2% | +$7.96K | 0.62% | 24 |
|
|
2026
Q1 | $4.13M | Sell |
18,973
-17
| -0.1% | -$3.77K | 0.59% | 26 |
|
|
2025
Q4 | $4.34M | Sell |
18,990
-994
| -5% | -$226K | 0.59% | 27 |
|
|
2025
Q3 | $4.63M | Sell |
19,984
-1,905
| -9% | -$388K | 0.63% | 24 |
|
|
2025
Q2 | $4.06M | Sell |
21,889
-32
| -0.1% | -$5.95K | 0.53% | 30 |
|
|
2025
Q1 | $4.59M | Sell |
21,921
-82
| -0.4% | -$15.9K | 0.56% | 33 |
|
|
2024
Q4 | $3.91M | Sell |
22,003
-245
| -1% | -$45K | 0.45% | 41 |
|
|
2024
Q3 | $4.39M | Buy |
22,248
+267
| +1% | +$49.8K | 0.51% | 35 |
|
|
2024
Q2 | $3.77M | Sell |
21,981
-74
| -0.3% | -$12.3K | 0.45% | 40 |
|
|
2024
Q1 | $4.02M | Buy |
22,055
+2,518
| +13% | +$434K | 0.49% | 37 |
|
|
2023
Q4 | $3.03M | Sell |
19,537
-688
| -3% | -$100K | 0.41% | 40 |
|
|
2023
Q3 | $3.01M | Sell |
20,225
-49
| -0.2% | -$7.19K | 0.45% | 38 |
|
|
2023
Q2 | $2.73M | Sell |
20,274
-3,166
| -14% | -$464K | 0.37% | 42 |
|
|
2023
Q1 | $3.74M | Buy |
23,440
+2,116
| +10% | +$324K | 0.49% | 28 |
|
|
2022
Q4 | $3.45M | Buy |
21,324
+6,491
| +44% | +$995K | 0.51% | 32 |
|
|
2022
Q3 | $1.99M | Buy |
14,833
+765
| +5% | +$110K | 0.35% | 41 |
|
|
2022
Q2 | $2.15M | Sell |
14,068
-65
| -0.5% | -$9.93K | 0.37% | 39 |
|
|
2022
Q1 | $2.29M | Hold |
14,133
| – | – | 0.33% | 43 |
|
|
2021
Q4 | $1.91M | Buy |
14,133
+300
| +2% | +$35.4K | 0.25% | 58 |
|
|
2021
Q3 | $1.49M | Buy |
13,833
+1,228
| +10% | +$140K | 0.2% | 72 |
|
|
2021
Q2 | $1.42M | Buy |
12,605
+817
| +7% | +$92K | 0.2% | 78 |
|
|
2021
Q1 | $1.28M | Sell |
11,788
-81
| -0.7% | -$8.66K | 0.19% | 83 |
|
|
2020
Q4 | $1.27M | Buy |
11,869
+50
| +0.4% | +$4.8K | 0.2% | 79 |
|
|
2020
Q3 | $1.03M | Sell |
11,819
-3,307
| -22% | -$311K | 0.16% | 85 |
|
|
2020
Q2 | $1.49M | Buy |
15,126
+727
| +5% | +$64K | 0.2% | 61 |
|
|
2020
Q1 | $1.1M | Hold |
14,399
| – | – | 0.18% | 67 |
|
|
2019
Q4 | $1.27M | Hold |
14,399
| – | – | 0.14% | 80 |
|
|
2019
Q3 | $1.09M | Sell |
14,399
-443
| -3% | -$30.4K | 0.13% | 84 |
|
|
2019
Q2 | $1.08M | Hold |
14,842
| – | – | 0.14% | 83 |
|
|
2019
Q1 | $1.2M | Sell |
14,842
-583
| -4% | -$47.7K | 0.15% | 69 |
|
|
2018
Q4 | $1.43M | Hold |
15,425
| – | – | 0.22% | 47 |
|
|
2018
Q3 | $1.46M | Hold |
15,425
| – | – | 0.21% | 49 |
|
|
2018
Q2 | $1.43M | Buy |
15,425
+9,543
| +162% | +$932K | 0.22% | 47 |
|
|
2018
Q1 | $557K | Sell |
5,882
-557
| -9% | -$61.2K | 0.09% | 124 |
|
|
2017
Q4 | $623K | Hold |
6,439
| – | – | 0.09% | 112 |
|
|
2017
Q3 | $572K | Hold |
6,439
| – | – | 0.09% | 109 |
|
|
2017
Q2 | $467K | Hold |
6,439
| – | – | 0.07% | 117 |
|
|
2017
Q1 | $420K | Sell |
6,439
-750
| -10% | -$47.2K | 0.07% | 127 |
|
|
2016
Q4 | $450K | Sell |
7,189
-856
| -11% | -$52.3K | 0.07% | 122 |
|
|
2016
Q3 | $507K | Sell |
8,045
-1,553
| -16% | -$101K | 0.08% | 121 |
|
|
2016
Q2 | $594K | Sell |
9,598
-1,000
| -9% | -$60.9K | 0.08% | 106 |
|
|
2016
Q1 | $605K | Sell |
10,598
-599
| -5% | -$33.4K | 0.08% | 104 |
|
|
2015
Q4 | $663K | Hold |
11,197
| – | – | 0.09% | 93 |
|
|
2015
Q3 | $609K | Hold |
11,197
| – | – | 0.1% | 83 |
|
|
2015
Q2 | $752K | Hold |
11,197
| – | – | 0.12% | 79 |
|
|
2015
Q1 | $655K | Sell |
11,197
-1,740
| -13% | -$105K | 0.1% | 85 |
|
|
2014
Q4 | $847K | Sell |
12,937
-1,740
| -12% | -$110K | 0.11% | 80 |
|
|
2014
Q3 | $848K | Buy |
14,677
+1,083
| +8% | +$60.1K | 0.11% | 74 |
|
|
2014
Q2 | $767K | Sell |
13,594
-50
| -0.4% | -$2.62K | 0.1% | 91 |
|
|
2014
Q1 | $701K | Buy |
13,644
+700
| +5% | +$35.4K | 0.11% | 100 |
|
|
2013
Q4 | $684K | Sell |
12,944
-670
| -5% | -$32.9K | 0.11% | 100 |
|
|
2013
Q3 | $609K | Sell |
13,614
-142
| -1% | -$6.29K | 0.1% | 105 |
|
|
2013
Q2 | $569K | Buy |
+13,756
| New | +$602K | 0.11% | 97 |
|
Other funds holding ABBV
Manchester Capital Management's ABBV Position: Q2 2026 in Review
Manchester Capital Management increased its AbbVie (ABBV) stake by 0.2% in Q2 2026, buying an estimated $7.96K and bringing the position to 19,010 shares worth $4.78M. The position accounts for 0.62% of the portfolio, ranked #24.
Manchester Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Manchester Capital Management held 19,010 shares of AbbVie worth $4.78M as of Q2 2026.
- Manchester Capital Management bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
- AbbVie made up 0.62% of Manchester Capital Management's portfolio in Q2 2026, its #24 holding.
- Manchester Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.